They were from an operable scar removal in California , I believe that was a previous scar that was surgically removed and then had extensive laser surgery etc to complete ,, its just a sample visual of what I believe SNT 6302 will be able to achieve in the form of a take home topical cream..
"In Privacy at Home" application for this type of cosmetic damage to " then repair" is hugely marketable , reducing the amount of social exposure to the damage that many become extremely self aware with.
Not having to drive to a clinic or Hospital for application ramps up the convenience.
To the best of my knowledge there is no Current SOC Standard of Care Treatment administered for Planned Surgical Incisions ,, If SNT 6302 can assist with reduction in existing scar tissue then through the same Mechanism of Action if applied to fresh surgical Incisions should deliver a hugely significant benefit literally preventing scar tissue in the first place.. This seems to be a First In Class Medicine as a Pan Lox Inhibitor...
This Technology was developed in house under PXS , 100% Ownership now under SNT and at Phase II Trial Readiness... Thats whats excites me about 2025 here at SNT ..
Back to the Pool for the rest of the Day ,, Family Time.... NZT
SNT Price at posting:
8.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)